|
1
|
Ma KX, Wang HJ, Li XR, Li T, Su G, Yang P
and Wu JW: Long noncoding RNA MALAT1 associates with the malignant
status and poor prognosis in glioma. Tumour Biol. 36:3355–3359.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Grossman SA, Ye X, Piantadosi S, Desideri
S, Nabors LB, Rosenfeld M and Fisher J: NABTT CNS Consortium:
Survival of patients with newly diagnosed glioblastoma treated with
radiation and temozolomide in research studies in the United
States. Clin Cancer Res. 16:2443–2449. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guo M, Zhang X, Wang G, Sun J, Jiang Z,
Khadarian K, Yu S, Zhao Y, Xie C, Zhang K, et al: miR-603 promotes
glioma cell growth via wnt/β-catenin pathway by inhibiting WIF1 and
CTNNBIP1. Cancer Lett. 360:76–86. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gu JJ, Gao GZ and Zhang SM: miR-218
inhibits the migration and invasion of glioma U87 cells through the
Slit2-Robo1 pathway. Oncol Lett. 9:1561–1566. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shang C, Hong Y, Guo Y, Liu YH and Xue YX:
MiR-210 up-regulation inhibits proliferation and induces apoptosis
in glioma cells by targeting SIN3A. Med Sci Monit. 20:2571–2577.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Feng J, Bi C, Clark BS, Mady R, Shah P and
Kohtz JD: The Evf-2 noncoding RNA is transcribed from the Dlx-5/6
ultraconserved region and functions as a Dlx-2 transcriptional
coactivator. Gnens Dev. 20:1470–1484. 2006. View Article : Google Scholar
|
|
7
|
Beltran M, Puig I, Peña C, García JM,
Alvarez AB, Peña R, Bonilla F and de Herreros AG: A natural
antisense transcript regulates Zeb2/Sip1 gene expression during
Snail1-induced epithelial-mesenchymal transition. Genes Dev.
22:756–769. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rinn JL, Kertesz M, Wang JK, Squazzo SL,
Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E and
Chang HY: Functional demarcation of active and silent chromatin
domains in human HOX loci by noncoding RNAs. Cell. 129:1311–1323.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Young TL, Matsuda T and Cepko CL: The
noncoding RNA taurine upregulated gene 1 is required for
differentiation of the murine retina. Curr Biol. 15:501–512. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu Y, Wang J, Qiu M and Xu L, Li M, Jiang
F, Yin R and Xu L: Upregulation of the long noncoding RNA TUG1
promotes proliferation and migration of esophageal squamous cell
carcinoma. Tumour Biol. 36:1643–1651. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang EB, Yin DD, Sun M, Kong R, Liu XH,
You LH, Han L, Xia R, Wang KM, Yang JS, et al: P53-regulated long
non-coding RNA TUG1 affects cell proliferation in human non-small
cell lung cancer, partly through epigenetically regulating HOXB7
expression. Cell Death Dis. 5:e12432014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yan G, Wang X, Yang M, Lu L and Zhou Q:
Long non-coding RNA TUG1 promotes progression of oral squamous cell
carcinoma through upregulating FMNL2 by sponging miR-219. Am J
Cancer Res. 7:1899–1912. 2017.PubMed/NCBI
|
|
15
|
Cuddapah VA, Robel S, Watkins S and
Sontheimer H: A neurocentric perspective on glioma invasion. Nat
Rev Neurosci. 15:455–465. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang K, Sun X, Zhou X, Han L, Chen L, Shi
Z, Zhang A, Ye M, Wang Q, Liu C, et al: Long non-coding RNA HOTAIR
promotes glioblastoma cell cycle progression in an EZH2 dependent
manner. Oncotarget. 6:537–546. 2015.PubMed/NCBI
|
|
17
|
Li Z, Zhao X, Zhou Y, Liu Y, Zhou Q, Ye H,
Wang Y, Zeng J, Song Y, Gao W, et al: The long non-coding RNA
HOTTIP promotes progression and gemcitabine resistance by
regulating HOXA13 in pancreatic cancer. J Transl Med. 13:842015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Han L, Zhang K, Shi Z, Zhang J, Zhu J, Zhu
S, Zhang A, Jia Z, Wang G, Yu S, et al: LncRNA profile of
glioblastoma reveals the potential role of lncRNAs in contributing
to glioblastoma pathogenesis. Int J Oncol. 40:2004–2012.
2012.PubMed/NCBI
|
|
19
|
Zhang JX, Han L, Bao ZS, Wang YY, Chen LY,
Yan W, Yu SZ, Pu PY, Liu N, You YP, et al: HOTAIR, a cell
cycle-associated long noncoding RNA and a strong predictor of
survival, is preferentially expressed in classical and mesenchymal
glioma. Neuro Oncol. 15:1595–1603. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shi Y, Wang Y, Luan W, Wang P, Tao T,
Zhang J, Qian J, Liu N and You Y: Long non-coding RNA H19 promotes
glioma cell invasion by deriving miR-675. PLoS One. 9:e862952014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang P, Ren Z and Sun P: Overexpression of
the long non-coding RNA MEG3 impairs in vitro glioma cell
proliferation. J Cell Biochem. 113:1868–1874. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qin X, Yao J, Geng P, Fu X, Xue J and
Zhang Z: LncRNA TSLC1-AS1 is a novel tumor suppressor in glioma.
Int J Clin Exp Pathol. 7:3065–3072. 2014.PubMed/NCBI
|
|
23
|
Han Y, Liu Y, Gui Y and Cai Z: Long
intergenic noncoding RNA TUG1 is overexpressed in urothelial
carcinoma of the bladder. J Surg Oncol. 107:555–559. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang Q, Geng PL, Yin P, Wang XL, Jia JP
and Yao J: Down-regulation of long non-coding RNA TUG1 inhibits
osteosarcoma cell proliferation and promotes apoptosis. Asian Pac J
Cancer Prev. 14:2311–2315. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu Q, Sun S, Yu W, Jiang J, Zhuo F, Qiu
G, Xu S and Jiang X: Altered expression of long non-coding RNAs
during genotoxic stress-induced cell death in human glioma cells. J
Neurooncol. 122:283–292. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jiang L, Zhang Q, Ren H, Ma S, Lu C, Liu
B, Liu J, Liang J, Li M and Zhu R: Dihydromyricetin enhances the
chemo-sensitivity of nedaplatin via regulation of the p53/Bcl-2
pathway in hepatocellular carcinoma cells. PLoS One.
10:e01249942015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shafiee SM, Rasti M, Seghatoleslam A,
Azimi T and Owji AA: UBE2Q1 in a human breast carcinoma cell line:
Overexpression and interaction with p53. Asian Pac J Cancer Prev.
16:3723–3727. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee K, Jung ES, Choi YJ, Lee KY and Lee A:
Expression of pRb, p53, p16 and cyclin D1 and their clinical
implications in urothelial carcinoma. J Korean Med Sci.
25:1449–1455. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yildirim M, Kaya V, Demirpence O, Gunduz S
and Bozcuk H: Prognosis significance of p53 in gastric cancer: A
meta-analysis. Asian Pac J Cancer Prev. 16:327–332. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Elhag R, Mazzio EA and Soliman KF: The
effect of silibinin in enhancing toxicity of temozolomide and
etoposide in p53 and PTEN-mutated resistant glioma cell lines.
Anticancer Res. 35:1263–1269. 2015.PubMed/NCBI
|
